Stockpolly
Search
CING · NASDAQ · Biotechnology

Cingulate (CING)

Develops once-daily ADHD medicines using a multi-core timed-release platform.

$5.16
At close+0.05 (+0.98%)
Watchlist

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Cost of revenue000000000000
Gross profit000000000000
673336456685
Research & development452214233221
221122123464
General & administrative201122123464
Other expenses000000000000
Operating income−6−7−3−3−3−6−4−5−6−6−8−5
0000−1000−1−1−10
Interest expense—0—000000−100
Other non-operating income000000000000
Income before tax−6−7−3−3−4−6−4−5−7−6−9−6
Net income from continuing operations−6−7−3−3−4−6−4−5−7−6−9−6
Net income−6−7−3−3−4−6−4−5−7−6−9−6
EPS, basic−$72.60−$18.62−$7.21−$1.09−$1.83−$1.80−$1.04−$1.09−$1.35−$0.87−$1.71−$1.08
EPS, diluted−$72.60−$18.62−$7.21−$1.09−$1.83−$1.80−$1.04−$1.09−$1.35−$0.87−$1.71−$1.08
Weighted average shares, basic232343445555
Weighted average shares, diluted232343445555
EBITDA−6−7−3−3−3−6−4−5−6−5−8214
Depreciation & amortization00000000000219
EBIT−6−7−3−3−3−6−4−5−6−6−8−6